Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA finds drugs in EZVille supplements

This article was originally published in The Tan Sheet

Executive Summary

The agency advises consumers to not use so-called "supplements" from EZVille Ltd. because they contain analogues of Rx ingredients. The Ronkonkoma, N.Y., company Aug. 6 recalled Revivexxx Extra Strength, promoted for sexual enhancement, and weight-loss product Solo Slim. FDA analysis found Revivexxx contains tadalafil, the active ingredient in the prescription erectile dysfunction drug Cialis, and Solo Slim contains sibutramine, found in Rx weight-loss drug Meridia. The products should be returned to the place of purchase, FDA said. ... Sulfoaildenafil spurs recalls: FDA finds the analogue of sildenafil, an active drug for erectile dysfunction, in two firms' products marketed as dietary supplements. On Aug. 9, the agency announced Salt Lake City-based Prolatis recalled its eponymous product, sold nationwide in double blister packs and 40-count bottles. On Aug. 10, FDA said another Salt Lake City firm, Novacare, recalled a range of affected products sold under names including Stiff Nights, Aziffa, Monster Excyte and others, distributed in bottles and blister cards to retailers and websites. Sulfoaildenafil is among the increasingly complex ranks of sildenafil analogues FDA regularly finds in adulterated supplements (1"The Tan Sheet" June 28, 2010)

You may also be interested in...



FDA Warning Letters In Brief

NovaCare cited for Viagra analogue

FDA Lifts Curtain On The Secret Behind Magic Power Coffee

FDA's consumer advisory against a coffee product that contains an active drug ingredient for erectile dysfunction reflects the agency's growing capability to keep up with noncompliant firms that add drug substances to so-called dietary supplements

Health And Wellness Trademark Review 14 January, 2020

Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.

Topics

UsernamePublicRestriction

Register

PS104402

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel